Sequencing of COVID-19: Comparison to SARS and bat coronavirus [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials
1. This cross-sectional study found that coronavirus 2019 (COVID-19) shared 79.6% genome sequence identity with severe acute respiratory syndrome-related coronavirus (SARS-CoV).
2. Additionally, COVID-19 shares 96% whole genome sequence with bat coronavirus.
Original Date of Publication: February 2020
Study Rundown: In this cross-sectional study, full-length genome sequences were obtained from the early COVID-19 outbreak in Wuhan, China. The sequence was compared to SARS-CoV BJ01 and was identified to belong to the species SARS-related coronaviruses (SARSr-CoV). Additionally, COVID-19 uses the same cell entry receptor as SARC-CoV. Full-length sequencing was also performed on a bat coronavirus (BatCoV RaTG13) which was found through phylogenetic analysis to be the closest identified relative to COVID-19. Although, the generalizability of the study results is severely limited by small sample size and lack of robust epidemiological data confirming infection etiology. In summary, this study demonstrated that COVID-19 is a SARSr-CoV which whole-genome similarity to BatCoV RaTG13.
Click to read the study in the Nature
EvidencePulse
How does Sequencing of COVID-19 apply to your patient?
Describe your patient and EvidencePulse weighs this trial against later evidence and current guidelines, with citations.
For a fuller review of the evidence, Deep research is a core feature of 2MM Max.
In-Depth [cross-sectional study]: The present cross-sectional study compared the whole-genome sequence of COVID-19 extracted from patients admitted to Wuhan Jin Yin-Tan Hospital (n = 5) to the whole genomes of SARS-CoV BJ01 and BatCoV RaTG13. Patients were originally presented with virus-induced pneumonia of unknown origin. Targeted PCR was used to obtain a COVID-19 genome which had 79.6% similarity to SARSr-CoV. The COVID-19 genome evaluated had six major open-reading frames and several accessory genes common to coronaviruses. Additionally, a virus infectivity study was conducted which determined that COVID-19 uses the same cell entry receptor-angiotensin converting enzyme II as SARS-CoV. Interestingly, overall sequence identity of COVID-19 had 96.2% similarity to BatCoV RaTG13.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature. 2020 Mar;579(7798):270-3.
Trials since this one
What later trials found on the same question.
- 2021
Third dose of BNT162b2 COVID-19 vaccine effective at decreasing risk of hospitalization In The Classics
Compared to two doses of the BNT162b2 vaccine, a third booster dose was estimated to be 93% effective against admission to hospital due to COVID-19 infection.
- 2021
Inactivated whole-virion SARS-CoV-2 vaccine reduces rates of symptomatic COVID-19 infections In The Classics
Incidence of PCR-confirmed symptomatic COVID-19 cases was lower in the vaccine group compared with the placebo group.
5 more since 2020
2MM+ See every trial since Sequencing of COVID-19
2MM+ shows the full timeline of later trials on this question, with what each one found, and lets you save trials to reading lists for rounds, journal club and boards.
Citation: Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3. PMID: 32015507; PMCID: PMC7095418.
© 2022 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine
Get the app